KalVista initiated with an Outperform at JMP Securities
JMP Securities initiated coverage of KalVista (KALV) with an Outperform rating and $19 price target KalVista is developing sebetralstat, a ...
JMP Securities starts Astria Therapeutics stock at Market Outperform
JMP Securities initiated coverage on Astria Therapeutics (NASDAQ: ATXS), assigning a Market Outperform rating and setting a ...
Uber has to use M&A to acquire AV technology, says JMP Securities
With Tesla (TSLA) planning to launch unsupervised full self-driving as a paid service in Austin in June and in California by year end while ...
JMP Securities raises Pharvaris stock target to $55
Wolleben's updated price target is a reflection of a revised revenue forecast for Pharvaris's prophylactic treatment, ...
bovnews14h
What’s Behind the -4.69% Drop in Sana Biotechnology Inc (SANA) Stock? Find Out Now!
Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $3.25 which represents a decrease of $-0.16 or -4.69% from the prior close of $3.41. The stock opened at $3.4 and touched a low of ...
bovnews19h
Innovid Corp (CTV) Stock: Unveiling Its Hidden Strengths
JMP Securities has recently reduced Innovid Corp (CTV) stock to Mkt Perform rating, as announced on November 21, 2024, according to Finviz. Analyst ratings are significant because they provide ...
MarketWatch18h
KKR & Co. Inc.
Ratos AB Series B 1.36% kr11.38B ...